Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRCM
2976
DELISTED
CARE.COM, INC.
CRCM
| $4.79M | ﹤0.01% |
436,701
+314,252
| +257% | +$4.75M |
|
2977
CALL
CRISPR Therapeutics
CRSP
$5.18B
| $4.79M | ﹤0.01% |
101,600
+23,000
| +29% | +$919K |
|
2978
PUT
JetBlue
JBLU
$2.13B
| $4.78M | ﹤0.01% |
258,600
-225,500
| -47% | -$4.03M |
|
2979
Trip.com Group
TCOM
$28.3B
| $4.78M | ﹤0.01% |
+129,368
| New | +$5.1M |
|
|
BLD
2980
PUT
DELISTED
TopBuild
BLD
| $4.77M | ﹤0.01% |
57,600
+35,500
| +161% | +$2.72M |
|
2981
Essent Group
ESNT
$6.25B
| $4.77M | ﹤0.01% |
101,438
-82,451
| -45% | -$3.88M |
|
2982
Genuine Parts
GPC
$18.6B
| $4.77M | ﹤0.01% |
46,018
-17,543
| -28% | -$1.82M |
|
|
BBBY
2983
CALL
Bed Bath & Beyond
BBBY
$415M
| $4.76M | ﹤0.01% |
465,850
-16,238
| -3% | -$152K |
|
|
CRON
2984
PUT
Cronos Group
CRON
$1.16B
| $4.76M | ﹤0.01% |
297,900
-290,700
| -49% | -$4.69M |
|
2985
Vornado Realty Trust
VNO
$7.28B
| $4.76M | ﹤0.01% |
74,254
-202,131
| -73% | -$13.6M |
|
|
SHLX
2986
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $4.76M | ﹤0.01% |
+229,566
| New | +$4.71M |
|
2987
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.05B
| $4.75M | ﹤0.01% |
93,217
+51,466
| +123% | +$2.58M |
|
2988
CALL
Western Midstream Partners
WES
$20.2B
| $4.75M | ﹤0.01% |
154,400
+91,700
| +146% | +$2.83M |
|
2989
PUT
Enbridge
ENB
$111B
| $4.75M | ﹤0.01% |
131,600
+21,300
| +19% | +$776K |
|
2990
CALL
Thor Industries
THO
$4.11B
| $4.75M | ﹤0.01% |
81,200
-30,000
| -27% | -$1.82M |
|
2991
CALL
ING
ING
$102B
| $4.74M | ﹤0.01% |
409,800
+151,000
| +58% | +$1.8M |
|
|
JMIA
2992
PUT
Jumia Technologies
JMIA
$772M
| $4.74M | ﹤0.01% |
+179,400
| New | +$5.17M |
|
|
BFYT
2993
PUT
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $4.74M | ﹤0.01% |
182,800
-52,400
| -22% | -$1.32M |
|
2994
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
| $4.73M | ﹤0.01% |
33,200
+1,600
| +5% | +$215K |
|
2995
Timken Company
TKR
$9.25B
| $4.73M | ﹤0.01% |
92,151
-43,252
| -32% | -$2.07M |
|
|
2996
CALL
JetBlue
JBLU
$2.13B
| $4.73M | ﹤0.01% |
255,700
-335,400
| -57% | -$6M |
|
2997
CALL
Xerox
XRX
$407M
| $4.72M | ﹤0.01% |
133,400
-43,400
| -25% | -$1.45M |
|
2998
PUT
Visteon
VC
$2.89B
| $4.72M | ﹤0.01% |
80,600
+42,700
| +113% | +$2.61M |
|
|
SWCH
2999
CALL
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $4.72M | ﹤0.01% |
360,300
-118,700
| -25% | -$1.4M |
|
3000
Northwest Natural Holdings
NWN
$2.14B
| $4.71M | ﹤0.01% |
67,764
+51,921
| +328% | +$3.51M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.